Our Executive Team
Centre Director
Prof YuanTong Gu
Read Bio
YuanTong leads a large research group in mechanical engineering with particular focus on nanotechnology and nanodevices. He is an expert in advanced experimental and numerical computational modelling for biomechanics. He is an ARC Future Fellow.
DEPUTY CENTRE DIRECTOR
Prof Peter Pivonka
Read Bio
Peter leads biomechanics research across the Faculty of Science and Engineering at QUT with a focus on transdisciplinary musculoskeletal research. His interests are in mechanobiology, multiscale modelling and bioengineering. He is the Chair of QUT Biomedical Engineering and also serves as the President of the Australia New Zealand Society of Biomechanics.
School Manager
Maddie McIntyre
Read Bio
Maddie is a biomedical engineer with extensive experience in managing business and operations in the medical technology sector. She is passionate about supporting the development of personalized medical technologies and facilitating their effective integration in the clinical setting. In her role as Centre Manager, Maddie guides the multidisciplinary team from academic, clinical and industry partners to reach the strategic goals of the Centre.
CLINICIAN
A/Prof Kenneth Cutbush
Read Bio
CLINICIAN
Prof Ashish Gupta (Adj)
Read Bio
Ashish is a Brisbane based subspecialist orthopaedic shoulder surgeon. He is the founder of QUASR and has keen biomechanical research interests having completed a Masters in Science. His list of publications includes papers in international peer reviewed journals and numerous book chapters. Ashish actively participates in orthopaedic education and training.
PROGRAM LEAD
Prof Lynne Bilston
Read Bio
Lynne is a biomedical engineer whose research focuses on how mechanical forces are involved in physiological and pathophysiological processes in the body. Her research encompasses injury biomechanics, neural and other soft tissue biomechanics, and the development of novel imaging methods for making biomechanical measurements in vivo, such as MR elastography. She has a PhD in bioengineering from the University of Pennsylvania and is a National Health and Medical Research Council of Australia Investigator fellow, and an elected fellow of the Australian Academy of Health and Medical Sciences. She is a Senior Principal Research Scientist at Neuroscience Research Australia, and a conjoint Professor at the University of New South Wales in the Faculty of Medicine.
PROGRAM LEAD
A/Prof Saulo Martelli
Read Bio
Saulo’s research focuses on musculoskeletal biomechanics. He aims at quantifying how shape, elasticity and physical activity determine musculoskeletal function in healthy and pathological adult people. He has pioneered computer methods for studying the neuro-muscle control system, quantifying the risk of bone fracture and informing exercise prescription in osteoporosis. He has advanced experimental techniques for studying the microstructural contribution to bone strength, real-time loading during normal physical activity and high-speed impact. He has optimized joint stability and strength in innovative joint replacements and developed computer technologies for conducting virtual trials of orthopaedic devices. He has also contributed to the development of software for integration clinical imaging toward a personalized, physics-based, medicine.
PROGRAM LEAD
Prof Justin Cooper-White
Read Bio
Justin is the Head of the School of Chemical Engineering at The University of Queensland (UQ) and Professor of Bioengineering in the UQ School of Chemical Engineering. He is Senior Group Leader in the Australian Institute for Bioengineering and Nanotechnology (UQ), Director of the Australian National Fabrication Facility – Queensland Node (ANFF-Q), Co-Director of the UQ Centre in Stem Cell Ageing and Regenerative Engineering (UQ-StemCARE), Chief Scientific Officer of Scaled Biolabs Inc., a lab-on-a chip start-up based in San Francisco, and Editor-in-Chief of APL Bioengineering, published by American Institute of Physics Publishing (New York). Justin’s research interests are in biomaterials, cell therapy, tissue engineering and regenerative medicine. He has over 200 journal papers, published in high impact journals in these fields. He has produced six Worldwide patent families that have reached National Phase Entry in USA, Europe, and Australia in the areas of formulation design for agriproducts, microbioreactor arrays and tissue engineering scaffolds.
PROGRAM LEAD
Prof Graham Kerr